0
0

FDASRA Act of 2022

12/29/2022, 6:33 PM

Congressional Summary of S 4535

Food and Drug Administration Simple Reauthorization Act of 2022 or the FDASRA Act of 2022

This bill reauthorizes the authority of the Food and Drug Administration to collect certain fees related to drugs, medical devices, and biosimilar biological products and modifies such fees, including the base fee amounts.

Read the Full Bill

Formatted TextPDFFormatted XML

Current Status of Bill S 4535

Bill S 4535 is currently in the status of Bill Introduced since July 14, 2022. Bill S 4535 was introduced during Congress 117 and was introduced to the Senate on July 14, 2022.  Bill S 4535's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 14, 2022

Bipartisan Support of Bill S 4535

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
0
Democrat Cosponsors
0
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4535

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4535

FDASRA Act of 2022
FDASRA Act of 2022
Food and Drug Administration Simple Reauthorization Act of 2022
Biosimilar User Fee Amendments of 2022
Generic Drug User Fee Amendments of 2022
Medical Device User Fee Amendments of 2022
Prescription Drug User Fee Amendments of 2022
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.

Comments

Sponsors and Cosponsors of S 4535

Richard Burr
Richard Burr
North CarolinaRepublican

Latest Bills

Protecting Families from AI Data Center Energy Costs Act
Bill HR 6529August 1, 2026
Prices on the Wall Act of 2026
Bill HR 9390August 1, 2026
Pipeline Safety Authorization Act of 2026
Bill HR 9338August 1, 2026
Ratepayer Protection Act
Bill HR 9340August 1, 2026
Tyler’s Law
Bill HR 2004August 1, 2026
Stop Pills That Kill Act
Bill HR 8005August 1, 2026
Load Forecasting Enhancement Act
Bill HR 9332August 1, 2026
EMRTAI Authorization Act of 2026
Bill HR 9616August 1, 2026
High-Capacity Grid Act
Bill HR 6633August 1, 2026
Combating Illicit Xylazine Act
Bill HR 1266August 1, 2026
FDASLA Act of 2022
Bill S 4348December 29, 2022
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Bill HR 6833September 5, 2023